Hikma Pharmaceuticals PLC stock news

Hikma Pharmaceuticals PLC stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

20 wire items

2026-10-28 10:00:00 UTC#527490newconfirmednews

US estrogen supply shortages expand beyond patches to include injectable and vaginal products, Reuters reports

reutersimportance 0.50trust 0.80Food and Drug Administration -0.30ProPharma 0Kevin Schipper 0+2 entities

2026-10-20 13:12:02 UTC#486647newconfirmednews

Hikma Pharmaceuticals highlights R&D strategy with over 330 products in pipeline, focusing on respiratory and nasal

quartrimportance 0.40trust 0.70Hikma Pharmaceuticals PLC +0.30

2026-09-28 05:00:00 UTC#375427newconfirmednews

Hikma Pharmaceuticals names Rebecca Hall CFO for Q1 2027; targets 5-6% R&D spend

tradingviewimportance 0.30trust 0.70Hikma Pharmaceuticals Plc +0.20Rebecca Hall +0.30Khalid Nabilsi 0+1 entities

2026-09-24 16:33:00 UTC#364147newconfirmednews

WSJ Health Care Market Talk: Commentary on Novartis, UCB, and Hikma Pharmaceuticals

wsjimportance 0.30trust 0.90Novartis AG 0UCB S.A. 0Hikma Pharmaceuticals PLC 0

2026-09-24 06:56:00 UTC#360557duplicateconfirmednews

Hikma Pharmaceuticals confirms ViiV Healthcare's Rebecca Hall as incoming CFO for Q1 2027

dow_jonesimportance 0.30trust 0.90Hikma Pharmaceuticals PLC +0.10ViiV Healthcare -0.10Rebecca Hall +0.10+2 entities

2026-09-24 06:20:22 UTC#360365duplicateconfirmednews

Hikma Pharmaceuticals appoints Rebecca Hall as CFO, Khalid Nabilsi to transition to Deputy CEO role

reutersimportance 0.30trust 0.90Hikma Pharmaceuticals PLC +0.10Rebecca Hall +0.20

2026-09-24 06:00:00 UTC#360299newconfirmednews

Hikma Pharmaceuticals appoints Rebecca Hall as Chief Financial Officer

dow_jonesimportance 0.40trust 0.90Hikma Pharmaceuticals PLC +0.20Rebecca Hall +0.20

2026-09-16 14:38:07 UTC#321437newconfirmednews

Hikma Launches Glucentra, First Generic Semaglutide Available in Saudi Arabia

reutersimportance 0.60trust 0.90Hikma Pharmaceuticals PLC +0.60Glucentra +0.60Saudi Arabia +0.40

2026-09-10 18:20:00 UTC#294334newconfirmedpress release

Hikma Pharmaceuticals files epinephrine nasal spray for regulatory review in US, Europe, UK, and Canada

pr_newswireimportance 0.40trust 1.00Hikma Pharmaceuticals PLC +0.40US Food and Drug Administration +0.30

2026-08-07 10:45:00 UTC#144168newconfirmednews

WSJ Health Care Market Talk: Analyst Insights on Hikma Pharmaceuticals, Novo Nordisk, and Merck

wsjimportance 0.30trust 0.80Hikma Pharmaceuticals PLC 0Novo Nordisk A/S 0Merck & Co., Inc. 0

2026-08-06 09:54:00 UTC#136069newconfirmednews

Hikma Pharmaceuticals reports strong sales and profit growth, reiterates full-year guidance

quartrimportance 0.40trust 0.60Hikma Pharmaceuticals PLC +0.40

2026-08-06 07:34:00 UTC#135477newconfirmednews

US Futures, European Stocks Rise; WPP Climbs 23%, TBC Bank Drops 7.9%

dow_jonesimportance 0.30trust 0.80S&P Dow Jones Indices LLC +0.10Dow Jones & Company, Inc. +0.10STOXX Ltd. +0.10+2 entities

2026-08-06 06:21:36 UTC#135076duplicateconfirmednews

Hikma Pharmaceuticals reports 9% rise in 1H core-operating profit

reutersimportance 0.30trust 0.90Hikma Pharmaceuticals plc +0.40

2026-08-06 06:00:00 UTC#134977updateconfirmeddata release

Hikma Pharmaceuticals reports 1H 2026 revenue of $1.73 billion

dow_jonesimportance 0.40trust 0.90Hikma Pharmaceuticals PLC +0.20

2026-08-06 06:00:00 UTC#134976duplicateconfirmednews

Hikma Pharmaceuticals reports 1H 2026 pretax profit of $287 million

dow_jonesimportance 0.40trust 0.80Hikma Pharmaceuticals PLC 0

2026-08-06 06:00:00 UTC#134974updateconfirmednews

Hikma Pharmaceuticals reports 1H 2026 pretax profit of $356 million

dow_jonesimportance 0.40trust 0.90Hikma Pharmaceuticals PLC +0.30

2026-08-06 06:00:00 UTC#134973updateconfirmeddata release

Hikma Pharmaceuticals reports 1H 2026 operating profit of $336 million

dow_jonesimportance 0.40trust 0.90Hikma Pharmaceuticals PLC +0.40

2026-08-06 06:00:00 UTC#134963duplicateconfirmednews

Hikma Pharmaceuticals reports 1H 2026 net profit of $223 million

dow_jonesimportance 0.30trust 0.90Hikma Pharmaceuticals PLC +0.20

2026-08-06 06:00:00 UTC#134961duplicateconfirmednews

Hikma Pharmaceuticals 1H 2026 EPS reported at $1.02

dow_jonesimportance 0.30trust 0.80Hikma Pharmaceuticals PLC 0

2026-08-06 06:00:00 UTC#134960newconfirmeddata release

Hikma Pharmaceuticals Reports 1H 2026 Adjusted EPS of $1.26

dow_jonesimportance 0.40trust 0.90Hikma Pharmaceuticals PLC +0.30